![](https://media.americanpharmaceuticalreview.com/m/28/article/614040.jpg)
AstraZeneca Completes Acquisition of Amolyt Pharma
AstraZeneca announced the successful completion of the acquisition of Amolyt Pharma, a clinical-stage biotechnology company focused on developing novel treatments for rare endocrine diseases. The acquisition bolsters the Alexion, AstraZeneca Rare Disease …